Status:

Red

Decision Date:

November 2022

Comments

RED: 

• NICE TA832 - Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. (Decision date - November 2022)
• Treatment of adults with advanced hormone-sensitive prostate cancer. NHSE commissioned. (Decision date - March 2023) 

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again